gonadotropin

Significant difference was obtained between the study and control group when these are viewed as a whole, for the following parameters: number of aspirated oocytes (11.93% vs 8.17%, p=0.000), estradiol values (2678.82 pg/ml vs 1702.90 pg/ml, p=0.000) total dose of gonadotropins (1759.78 vs 2325.13, p=0.000) and applied protocol (p=0.014).

However, GnRH expression levels in Groups D and E increased to some extent, indicating that BSZYF may be involved in regulating gonadotropin levels (Fig.

Piscine glycoprotein hormone (gonadotropin and thyrotropin) receptors: a review of recent developments.

Bone mineral density and body composition before and during treatment with gonadotropin releasing hormone agonist in children with central precocious and early puberty.

TVU monitoring was performed in all patients to check follicle growth at certain intervals until the day of human chorionic gonadotropin (hCG) injection, when the lead follicle reached [greater than or equal to]18 mm in the CC alone group and [greater than or equal to]17 mm in the uFSH alone and sequential CC-uFSH groups, which was followed by a single IUI procedure at around 36-40 hours after subcutaneous hCG injection (10.000 IU).

Although hCG can be measured in both serum and urine specimens, urinary gonadotropin fragment (UGF) is detected solely in urine samples that may explained by the high metabolic clearance rate of hCG free [beta]-subunit.

Utility of commonly used commercial human chorionic gonadotropin immunoassays in the diagnosis and management of trophoblastic diseases.

Predicting pregnancy outcome after in vitro fertilization and embryo transfer using estradiol, progesterone, and human chorionic gonadotropin beta-subunit.

According to the Cochrane review on ovarian stimulation protocols for IUI in the women with subfertility, use of gonadotropins for COS in IUI results in higher pregnancy rate than clomiphene citrate stimulated cycles.

Hormonal investigations showed low testosterone (13.6 ng/mL) with high gonadotropin (follicle-stimulating hormone = 6.1 IU/L and LH = 12.53 IU/L) and AMH (> 23 ng/mL) levels.

A mean clinical pregnancy rate of 17.1% and live birth rate of 11.4% per cycle have been reported in literature following treatment of subfertile patients with gonadotropin stimulation and IUI.2,3 Various determinants of pregnancy such as the maternal age, aetiology and duration of infertility, endometrial thickness and number of preovulatory follicles have been reported, but the definitive determinants of success and the magnitude to which each factor contributes to positive pregnancy outcomes are still not unequivocal.2-4

Although none of medical strategies is completely effective, there is high-quality evidence that replacing human chorionic gonadotropin (hCG) by gonadotropin-releasing hormone (GnRH) agonists after GnRH antagonists and moderate-quality evidence that GnRH antagonist protocols, dopamine agonists and mild protocols reduce the occurrence of OHSS.

The Effect of Four Different Gonadotropin Protocols on Oocyte and Embryo Quality and Pregnancy Outcomes in IVF/ICSI Cycles; A Randomized Controlled Trial.

The ability of the oocyte to be fertilized is largely determined by the morphological and functional changes that are caused by hormonal events, specifically the fluctuation of gonadotropin hormones.

Accordingly, in Results, the text reading "The number of euploid embryos was negatively related to the OSI (p = 0.04), which indicates that the women who produced more oocytes in response to lower gonadotropin doses (low OSI) were those who displayed more euploid" should be changed to "The number of euploid embryos was positively related to the OSI (p = 0.04), which indicates that the women who produced more oocytes in response to lower gonadotropin doses (high OSI) were those who displayed more euploid."